Webinar

Beyond box checking

Five best practices for embedding QC in modern SCEs

Register now

June 17 at 11 AM PT | 1 PM ET | 30 min session

Quality control (QC) is a cornerstone of regulatory confidence in clinical trial analyses, yet it is too often treated as a separate, downstream activity rather than an integrated part of the workflow.

This webinar explores best practices for embedding QC directly into statistical computing environments (SCEs), ensuring quality is built in from the start — not bolted on at the end.

Drawing on lessons from global clinical teams, attendees will gain practical strategies to:

Embed QC without slowing science

Embed QC without slowing science

streamlining checks so they enhance, rather than hinder, day-to-day analytical work

compliance_icon

Balance compliance with exploratory flexibility

maintaining regulatory rigor while supporting innovative, iterative research

Strengthen collaboration

Strengthen collaboration

between statisticians and programmers to reduce rework and improve submission readiness

quality_assurance

Shift QC upstream

across data, code, and environments to deliver continuous quality assurance rather than point-in-time reviews

By moving beyond checklists and embedding quality into daily practice, this webinar offers an actionable approach that strengthens reproducibility and builds lasting regulatory confidence in clinical analytics.


Featured speaker

Matt Tendler

Product manager for life sciences


Currently leading Product Management for Domino Data Lab's Life Sciences division, Matt oversees product initiatives for the biopharmaceutical industry. Prior to joining Domino, Matt held senior product leadership roles at Medidata Solutions and ArisGlobal, where he architected Data Fabric and Analytics solutions, bringing more than ten analytics tools to market that advance clinical trial efficiency and safety signal detection capabilities across the industry. Throughout his career, Matt has successfully helped implement agile and quality practices across organizations of all sizes, from emerging medical device companies to global pharmaceutical enterprises.